Title Category Credit Event datesort descending Cost
Immunotherapy: Breakthroughs in Treatment
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 Learn about recent advances in the field of immunotherapy, examine the ongoing developments in CAR T-cell therapy, and discuss its safety, advantages, concerns, and clinical trials. 
Systemic Lupus Erythematosus: Mainstays of Management and Advances in Treatment
  • Disease management
  • Rare diseases
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 This activity will provide a review of SLE treatment guidelines, identification of new add-on treatments, and an understanding of how to establish and reach treatment goals can improve outcomes and increase remission rates, as current treatment often involves a trial-and-error approach that can be frustrating for health care providers and patients alike. 
Providing Quality Care for Adults With Intellectual and Developmental Disabilities
  • Intellectual and developmental disabilities
  • 2.00 ACPE - Pharmacists
  • 2.00 ACPE - Pharmacy Technicians
  • 2.00 AMA - Physicians
  • 2.00 ANCC - Nurses
  • 2.00 APA - Psychologists
  • 2.00 Attendance - General Attendance
  • 2.00 CCMC - General - Case Managers
  • 2.00 CDR - Dietitians
  • 2.00 COPE - Optometrists
  • 2.00 ASWB - Social Workers
 $0.00 This activity will provide learners with an overview of clinical considerations in adults with IDD and improve communication skills and practices that can better guide treatment choices to address the specific needs of these individuals. Learners will take a closer look at existing bias, stigma and discrimination toward these individuals and learn strategies to address these issues in practice. Lastly, the value of improved interprofessional team collaboration between health care professionals (HCPs), caregivers and direct support professionals will be discussed.
Innovation Through the Lens of the Patient: A Personal Transplant Experience
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 Join us during this activity to gain a new perspective on what is considered essential to many patients throughout the continuum of transplant care, such as communication, compassion, and discussion of expectations and quality-of-life goals. Hearing the experiences of patients who have undergone transplant procedures will provide additional insight into realizing a holistic approach to care based on an understanding of how patients perceive their illness, the transplant process (from diagnosis to procedure to postoperative management), and the potential impact on their lives.  
The Opioid Epidemic: The Impact of COVID-19 and Resulting Effects on Organ Transplantation
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
 $0.00 This activity will examine the influence of the COVID-19 pandemic on mental health and the opioid epidemic, how these phenomena have affected donor organ supply, and the projected implications for transplantation in the near future.
Type 2 Diabetes: What’s New?
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 This activity will provide an overview of the latest innovations in technology, new drugs and therapies, revised treatment regimens, monitoring strategies, and new research. It will review preventive and risk-reducing strategies, approaches to monitoring, the long-term sequelae, and interventions to improve outcomes.
Medicine in the Age of CRISPR: The Gene-Edited Patient
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 Gene therapy applications are vast and rapidly expanding, allowing for the treatment of gene alterations due to genetic diseases, HIV, coronary artery disease, and cancer. Gene editing with CRISPR/Cas9 is a straightforward method of site-specific gene editing with apparent advantages over traditional gene therapy. Learn how gene therapy is currently being used to combat disease and gain a better understanding of the mechanisms of action behind gene therapy and CRISPR/Cas9 gene editing. 
Initiatives to Address Diversity in Oncology
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
 $0.00 A lack of meaningful representation of certain racial and ethnic minorities persists in many fields of medicine, including that of oncology, despite diversity’s association with (as stated by the Institute of Medicine) “improved access to care for racial and ethnic minority patients, greater patient choice and satisfaction, better patient-provider communication, and better educational experiences for all students while in training.” Explore the multiple initiatives that have been created to remedy inequities that impact health outcomes for minority groups—such as disparities in social determinants of health and access to a high-quality and ethnically diverse oncology workforce.  
Unveiling Bipolar Disorder in the Pediatric Population
  • Behavioral health
  • Pediatrics
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 This activity will provide participants with a better understanding of the prevalence, clinical manifestations, and differential diagnoses for bipolar disorder in children and adolescents and will analyze the common childhood presentations of individuals later diagnosed with bipolar disorder as adults. The expert presenter will also review lessons learned in her own experience treating pediatric patients with bipolar disorder to provide insight into the diagnostic and therapeutic processes that can effectively treat this disorder in affected individuals.
Perinatal Behavioral Health With a Focus on Substance Use Disorder
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
 $0.00 Identification and early intervention for pregnant and postpartum women with substance-use disorders (SUD) are critical for optimizing maternal and neonatal health and wellbeing. The risk factors, common barriers to treatment, evidence-based practices around screening and interventions, and the framework for collaborative strategies to support pregnant and postpartum women with SUD will be discussed.

Pages